Advertisement
Advertisement
U.S. Markets open in 6 hrs 56 mins
Advertisement
Advertisement
Advertisement
Advertisement

GeoVax Labs, Inc. (GOVX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.6900-0.2300 (-5.87%)
At close: 04:00PM EST
Advertisement
Sign in to post a message.
  • E
    Ev-trader
    what do you think guys
  • G
    Geoffrey
    GeoVax presenting more data on their vaccines. All they do is present data and all that happens is the price goes down. Not good for shareholders.
    Bearish
  • E
    End2War
    The world badly needs a new vaccine that is not solely focused at the spike protein. This is one of the few established companies working on such a vaccine that could potentially stop the new virus, Omicron. Suddenly GOVX should draw far more interest due to what now looks to be a potential worldwide emergency. GOVX may be working on something that could help with the current crisis, and if so, it may qualify for government or private help, including funding or possibly even a buyout by a stronger company. The very small float here raises the possibility this could become a volatile issue.
  • w
    william
    I would not put money here unless quick flip, been following this forever and it only goes one way long term. Hype machine but nothing comes of it. Just my opinion be careful with your money here.
  • B
    BullCall56
    GeoVax Labs presented data from ongoing studies of its investigational vaccines against hemorrhagic fevers at the recent World Vaccine & Immunotherapy Congress, held November 30 - December 2 in San Diego, California. The presentation, titled "Design and Evaluation of Vaccines Against Hemorrhagic Fevers using the MVA-VLP Platform", was delivered by Mary Hauser, PhD, GeoVax Senior Scientist. In her talk, Dr. Hauser discussed the preclinical efficacy of GeoVax's vaccines against Sudan and Marburg (MARV) viruses, two highly virulent filovirus strains that cause hemorrhagic fever. Recent studies in lethal challenge guinea pig models demonstrated that GeoVax vaccines MVA-VLP-SUDV and MVA-VLP-MARV conferred 100% protection from death. These vaccines were subsequently evaluated in a rigorous cynomolgus macaque infectious challenge model. Vaccination protected nonhuman primates from viremia, weight loss and death following challenge with a dose of Sudan or Marburg virus that is lethal in nonvaccinated animals. Evaluation of immune responses following vaccination demonstrated presence of both neutralizing antibodies and functional T cells, indicating a breadth of responses that combine for optimal protection. Mark Newman, PhD, GeoVax Chief Scientific Officer, commented, "The ability of vaccines based on the GV-MVA-VLP platform to induce protective immunity from such deadly pathogens is impressive. We believe these results support further development efforts with our partners and collaborators towards clinical evaluation to document safety and immunogenicity in humans."

    Read more at:
    https://thefly.com/n.php?id=3420950
  • S
    Saved by grace
    Trust in JESUS.
  • B
    Beans
    3 million in pre-market volume. No news, outside what is driving the markets. There has to be something more to this other than the usual pump n dump?
  • J
    JUAN
    Guys, no doubt this will be trading at double digits anytime between now and 2057. Don’t miss the opportunity
  • S
    Saved by grace
    Blessings
  • B
    Beans
    Sold! Had to based on zero news and the history of pump and dump - bought this week at $3.66. Did this a couple weeks back. Thank you for giving me some of my money back I lost years ago on reverse splits and dilution!
  • B
    Bart
    Con artists silent today.
  • W
    William
    This company will never produce a vaccine.
  • A
    Alexandra
    we cure cancer also we be selling popcorn soon! is that a the news people need to buy now?
    Neutral
  • B
    Be.long &Strong
    Will Hit $6 soon then $7.50 👆🏻
    Bullish
  • s
    shortsqueeze
    RVPH =CHEAPEST biotech OUT there ,next SAVA for your portfolio which went from $3 to $130

    (RVPH) MCap $49 m--Cash $34 m --A PHASE 3 company targeting several Blockbuster indications like Alzheimer ,Parkinson ,ADHD and so forth = Undiscovered Goldmine with 10 bagger upside potential guys
    https://assets.wallstreet-online.de/_media/8763/board/20210129182939-screenshot-2021-01-29-form-8-k-tenzing-acquisitio.png

    #+#+
  • M
    Melvin Capital
    baggies being made
    Bearish
  • M
    Melvin Capital
    3.95 today
    Bearish
  • B
    Beans
    I bought at $3.85 couple days ago and sold at $5.35. Gotta sell on the news. May run up to $6 in short-term, but this will go back to under $4 in time.
  • P
    Peter
    This is the next SAVA.
  • C
    ChelliM
    GeoVax (GOVX) - Gedeptin® Addition Expands GeoVax Immuno-Oncology Pipeline Into Clinical-Stage
    geovax-govx.reportablenews.com
Advertisement
Advertisement